Summary

Congresswoman Anna Paulina Luna (R-FL) has announced that the U.S. House of Representatives will hold a hearing on May 13, 2026, to examine the CIA’s MK-Ultra program, a covert Cold War-era initiative involving mind control and unethical human experimentation. The hearing, convened by the House Oversight Task Force on the Declassification of Federal Secrets under Luna’s leadership, will scrutinize the legacy of MK-Ultra, the government’s record of disclosure, and the broader implications for public trust in federal institutions. Established in 1953, MK-Ultra involved experiments with drugs such as LSD, hypnosis, and sensory deprivation, often without informed consent. The program’s exposure in the 1970s led to congressional investigations, partial declassification, and new safeguards against non-consensual human experimentation. The upcoming hearing reflects ongoing concerns about transparency, accountability, and the need to address unresolved questions surrounding MK-Ultra’s impact.

 

Detailed Report 

1. Congressional Hearing Announcement
On April 29, 2026, Congresswoman Anna Paulina Luna publicly announced that the House Oversight Task Force on the Declassification of Federal Secrets will hold a hearing on May 13, 2026, focused on the CIA’s MK-Ultra program. The announcement was made via Luna’s official social media channels and confirmed by multiple news outlets. The hearing is part of the Task Force’s ongoing efforts to promote transparency and public access to historically significant federal records.

 

2. Committee and Hearing Objectives
The House Oversight Task Force, chaired by Luna, is responsible for investigating and promoting the declassification of federal records, particularly those related to controversial government actions. The stated objective of the upcoming hearing is to examine the legacy of MK-Ultra, assess the government’s handling of related records, and address the impact of secrecy on public trust. Luna has emphasized the importance of restoring confidence in government through full disclosure of historical abuses.

 

3. Background: Origins of MK-Ultra
MK-Ultra was officially launched in April 1953 by CIA Director Allen Dulles amid Cold War fears of communist “brainwashing.” The program sought to develop methods of mind control, behavioral modification, and interrogation, building on earlier CIA projects such as BLUEBIRD and ARTICHOKE. The initiative ultimately encompassed 149 subprojects and involved at least 80 institutions across the United States and Canada.

 

4. Experimental Methods and Human Subjects
MK-Ultra’s experiments included the administration of psychoactive drugs (notably LSD), hypnosis, sensory deprivation, electroshock therapy, and sleep deprivation. Many subjects—ranging from psychiatric patients and prisoners to members of the general public—were exposed to these methods without their knowledge or informed consent. The program’s reach extended internationally, with secret detention centers established in Europe and East Asia.

 

5. Architects and Major Players: Gottlieb and West
5A. Dr Sidney Gottlieb

The design and execution of MK-Ultra were shaped by two principal figures: Dr. Sidney Gottlieb and Dr. Louis Jolyon “Jolly” West. Sidney Gottlieb, a chemist who joined the CIA in 1951, was appointed Chief of the Chemical Division within the Technical Services Staff and later became Director of the TSS. As the principal architect of MK-Ultra, Gottlieb oversaw at least 149 subprojects conducted at more than 80 institutions. He was responsible for acquiring the world’s entire supply of LSD in the early 1950s and orchestrated covert experiments involving LSD, amphetamines, barbiturates, mescaline, and other substances. These experiments, often conducted without the subjects’ consent, included methods such as electroshock, sensory deprivation, and sleep deprivation. In 1973, under orders from CIA Director Richard Helms, Gottlieb personally oversaw the destruction of the bulk of MK-Ultra records, which severely hampered subsequent investigations. Gottlieb later testified before congressional committees, including the Church Committee and the Senate Select Committee on Intelligence, but claimed limited recollection of program details. No criminal charges were ever brought against him.

5B. Dr Louis Jolyon

Dr. Louis Jolyon “Jolly” West, a psychiatrist with an MD from the University of Minnesota Medical School and a residency at Payne Whitney Psychiatric Clinic, was another key figure in MK-Ultra. Appointed as a full professor and chair of psychiatry at the University of Oklahoma at age 29, West later led the Neuropsychiatric Institute at UCLA. He held top-secret CIA security clearance and served as principal investigator for MK-Ultra Subproject 43, which focused on hypnosis, sensory deprivation, and the use of psychoactive drugs. West’s research, funded by the CIA through front organizations, aimed to extract information from unwilling subjects, implant false memories, and induce specific mental disorders. In 1956, he reported success in replacing true memories with false ones in human subjects without their knowledge. West maintained a close working relationship with Gottlieb, who acted as his CIA handler, and their correspondence is preserved in both declassified CIA files and West’s personal papers. West’s later work included establishing a CIA-funded apartment in San Francisco for covert behavioural studies.

 

6. Exposure and Congressional Scrutiny
MK-Ultra remained secret until the 1970s, when investigative reporting and congressional inquiries—most notably the 1975 Church Committee and 1977 Senate hearings—revealed the program’s scope. The discovery of 20,000 misfiled documents through a Freedom of Information Act request provided further evidence of the CIA’s activities. These investigations led to public condemnation and calls for reform.

 

7. Official Outcomes and Legacy
Following the exposure of MK-Ultra, the CIA acknowledged the program’s existence and admitted to many abuses. However, the destruction of most records in 1973 limited the full accounting of its activities. President Gerald Ford issued an executive order in 1976 prohibiting non-consensual drug experimentation by federal agencies. Some victims received financial settlements, but no senior officials were held criminally accountable. The legacy of MK-Ultra continues to influence debates on government transparency and ethical standards in intelligence operations.

 

Conclusion

Congresswoman Luna’s announcement of a May 2026 hearing on the CIA’s MK-Ultra program signals renewed congressional attention to historical intelligence abuses and the importance of transparency. The hearing is expected to address unresolved questions about the program’s legacy and the government’s commitment to accountability and public trust.